Advertisement

The Indian Journal of Pediatrics

, Volume 85, Issue 9, pp 763–772 | Cite as

Severe Asthma: Challenges and Pitfalls in Management

  • Anirban Maitra
Review Article

Abstract

A small but significant subset of asthmatic children show a lack of response to standard management, resulting in further intensification of therapy to optimise symptom control and may remain symptomatic despite maximal therapy. Severe asthma results in increased risk of adverse outcomes whilst contributing significantly to the economic burden on the nation’s health resources. The ERS / ATS guidelines were published in 2014 and form the basis of identifying, evaluating and managing severe asthmatic children. However, much of this evidence is extrapolated from adult studies and may be inappropriate in children as unlike adults, children have a more atopic phenotype. Severe asthma is an umbrella term and may represent several overlapping heterogeneous wheezing entities. This chapter aims at discussing the strategies employed in managing severe asthmatic children with particular focus on diagnostic challenges and management pitfalls. Particular emphasis is put into the logical and systematic approach to a child with severe asthma and describes the multidisciplinary approach to manage these children. Finally, this chapter describes the novel therapies available in children and in adults in managing this challenging condition.

Keywords

Severe asthma Severe therapy resistant asthma Asthma plus Difficult asthma Biologic therapy 

Notes

Compliance with Ethical Standards

Conflict of Interest

None.

References

  1. 1.
    Lang A, Carlsen KH, Haaland G, et al. Severe asthma in childhood: assessed in 10 year olds in a birth cohort study. Allergy. 2008;63:1054–60.CrossRefPubMedGoogle Scholar
  2. 2.
    Nordlund B, Melén E, Schultz ES, Grönlund H, Hedlin G, Kull I. Prevalence of severe childhood asthma according to the WHO. Respir Med. 2014;108:1234–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Fleming L, Wilson N, Bush A. Difficult to control asthma in children. Curr Opin Allergy Clin Immunol. 2007;7:190–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343–73.CrossRefPubMedGoogle Scholar
  5. 5.
    Bush A, Saglani S. Management of severe asthma in children. Lancet. 2010;376:814–25.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Hedlin G, Bush A, Carlsen KL, et al. Problematic severe asthma in children, not one problem but many: a GA2LEN initiative. Eur Respir J. 2010;36:196–201.CrossRefPubMedGoogle Scholar
  7. 7.
    Fitzpatrick AM. Severe asthma in children: lessons learned and future directions. J Allergy Clin Immunol Pract. 2016;4:11–9.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Cook J, Beresford F, Fainardi V, et al. Managing the pediatric patient with refractory asthma: a multidisciplinary approach. J Asthma Allergy. 2017;10:123–30.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Ramratnam SK, Bacharier LB, Guilbert TW. Severe asthma in children. J Allergy Clin Immunol Pract. 2017;5:889–98.CrossRefPubMedGoogle Scholar
  10. 10.
    Bush A, Fleming L, Saglani S. Severe asthma in children. Respirology. 2017;22:886–97.CrossRefPubMedGoogle Scholar
  11. 11.
    Fleming L, Murray C, Bansal AT, et al. The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts. Eur Respir J. 2015;46:1322–33.CrossRefPubMedGoogle Scholar
  12. 12.
    Bush A, Fleming L. Is asthma overdiagnosed? Arch Dis Child. 2016;101:688–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Bush A, Nagakumar P. Preschool wheezing phenotypes. Eur Med J [Internet]. 2016 Jan 26. Available at: http://emjreviews.com/therapeutic-area/respiratory/preschool-wheezing-phenotypes/. Accessed on 15 Feb 2018.
  14. 14.
    Kelly YJ, Brabin BJ, Milligan PJ, Reid JA, Heaf D, Pearson MG. Clinical significance of cough and wheeze in the diagnosis of asthma. Arch Dis Child. 1996;75:489–93.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Cane R, Ranganathan S, McKenzie S. What do parents of wheezy children understand by “wheeze”? Arch Dis Child. 2000;82:327–32.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Cane R, McKenzie S. Parents’ interpretations of children’s respiratory symptoms on video. Arch Dis Child. 2001;84:31–4.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Levy DML, Godfrey S, Irving CS, et al. Wheeze detection: recordings vs. assessment of physician and parent. J Asthma. 2004;41:845–53.CrossRefPubMedGoogle Scholar
  18. 18.
    Saglani S, McKenzie S, Bush A, Payne D. A video questionnaire identifies upper airway abnormalities in preschool children with reported wheeze. Arch Dis Child. 2005;90:961–4.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Kantar A, Chang AB, Shields MD, et al. ERS statement on protracted bacterial bronchitis in children. Eur Respir J. 2017;50. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593377/. Accessed on 15 Feb 2018.
  20. 20.
    Johansson H, Norlander K, Berglund L, et al. Prevalence of exercise-induced bronchoconstriction and exercise-induced laryngeal obstruction in a general adolescent population. Thorax. 2015;70:57–63.CrossRefPubMedGoogle Scholar
  21. 21.
    Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRefPubMedGoogle Scholar
  22. 22.
    Horváth I, Barnes PJ, Loukides S, et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respir J. 2017;49(4).  https://doi.org/10.1183/13993003.00965-2016.
  23. 23.
    Coates AL, Wanger J, Cockcroft DW, et al; The Bronchoprovocation Testing Task Force. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017;49(5).  https://doi.org/10.1183/13993003.01526-2016.
  24. 24.
    Cotes JE, Reed JW. Recommendations on the use of exercise testing in clinical practice. Eur Respir J. 2007;29:1064–6.  https://doi.org/10.1183/09031936.00006607.
  25. 25.
    Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RF, Sorkness CA. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med. 2004;170:426–32.CrossRefPubMedGoogle Scholar
  26. 26.
    Sorkness RL, Teague WG, Penugonda M, Fitzpatrick AM. Gender-dependence of airflow limitation and air trapping in children with severe asthma. J Allergy Clin Immunol. 2011;127:1073–4.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Maitra A. Assessment of airway inflammation. In: Lodha R, Kabra SK, editors. Essential Pediatric Pulmonology, 3rd ed. New Delhi: Jaypee Brothers; 2018. p. 428.Google Scholar
  28. 28.
    Gibson P, Simpson J, Hankin R, Powell H, Henry R. Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma. Thorax. 2003;58:116–21.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Bossley CJ, Fleming L, Gupta A, et al. Pediatric severe asthma is characterized by eosinophilia and remodeling without TH2 cytokines. J Allergy Clin Immunol. 2012;129:974–82.e13.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Low K, Lau KK, Holmes P, et al. Abnormal vocal cord function in difficult-to-treat asthma. Am J Respir Crit Care Med. 2011;184:50–6.CrossRefPubMedGoogle Scholar
  31. 31.
    Mehlum CS, Walsted ES, Godballe C, Backer V. Supraglottoplasty as treatment of exercise induced laryngeal obstruction (EILO). Eur Arch Otorhinolaryngol. 2016;273:945–51.CrossRefPubMedGoogle Scholar
  32. 32.
    Boulet L-P. Asthma and obesity. Clin Exp Allergy. 2013;43:8–21.CrossRefPubMedGoogle Scholar
  33. 33.
    Weinmayr G, Forastiere F, Büchele G, Jaensch A, Strachan DP, Nagel G. Overweight/obesity and respiratory and allergic disease in children: international study of asthma and allergies in childhood (ISAAC) phase two. PLoS ONE. 2014;9. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256390/. Accessed on 16 Feb 2018.
  34. 34.
    Carroll CL, Stoltz P, Raykov N, Smith SR, Zucker AR. Childhood overweight increases hospital admission rates for asthma. Pediatrics. 2007;120:734–40.CrossRefPubMedGoogle Scholar
  35. 35.
    Forno E, Lescher R, Strunk R, Weiss S, Fuhlbrigge A, Celedón JC. Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol. 2011;127:741–9.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Kouzouna A, Gilchrist FJ, Ball V, et al. A systematic review of early life factors which adversely affect subsequent lung function. Paediatr Respir Rev. 2016;20:67–75.PubMedGoogle Scholar
  37. 37.
    Tantisira K, Weiss S. Complex interactions in complex traits: obesity and asthma. Thorax. 2001;56:ii64–73.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Umetsu DT. Mechanisms by which obesity impacts upon asthma. Thorax. 2017;72:174–7.CrossRefPubMedGoogle Scholar
  39. 39.
    van Huisstede A, Rudolphus A, Castro Cabezas M, et al. Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma. Thorax. 2015;70:659–67.CrossRefPubMedGoogle Scholar
  40. 40.
    Roberts G, Patel N, Levi-Schaffer F, Habibi P, Lack G. Food allergy as a risk factor for life-threatening asthma in childhood: a case-controlled study. J Allergy Clin Immunol. 2003;112:168–74.CrossRefPubMedGoogle Scholar
  41. 41.
    Murray CS, Poletti G, Kebadze T, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax. 2006;61:376–82.CrossRefPubMedGoogle Scholar
  42. 42.
    Morgan WJ, Crain EF, Gruchalla RS, et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med. 2004;351:1068–80.CrossRefPubMedGoogle Scholar
  43. 43.
    de Groot EP, Nijkamp A, Duiverman EJ, Brand PLP. Allergic rhinitis is associated with poor asthma control in children with asthma. Thorax. 2012;67:582–7.CrossRefPubMedGoogle Scholar
  44. 44.
    Holbrook JT, Wise RA, Gold BD, et al. Randomized clinical trial of lansoprazole for poorly controlled asthma in children. JAMA. 2012;307:373–81.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Lang JE, Hossain J, Holbrook JT, et al. Gastro-oesophageal reflux and worse asthma control in obese children: a case of symptom misattribution? Thorax. 2016;71:238–46.CrossRefPubMedGoogle Scholar
  46. 46.
    Chan AHY, Stewart AW, Foster JM, Mitchell EA, Camargo CA, Harrison J. Factors associated with medication adherence in school-aged children with asthma. ERJ Open Res 2016; 2(1). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005164/. Accessed on 17 Feb 2018.
  47. 47.
    Bracken M, Fleming L, Hall P, et al. The importance of nurse-led home visits in the assessment of children with problematic asthma. Arch Dis Child. 2009;94:780–4.CrossRefPubMedGoogle Scholar
  48. 48.
    Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105:930–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Sleath B, Ayala GX, Gillette C, et al. Provider demonstration and assessment of child device technique during pediatric asthma visits. Pediatrics. 2011;127:642–8.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J. 2013;41:716–26.CrossRefPubMedGoogle Scholar
  51. 51.
    Peat JK, Keena V, Harakeh Z, Marks G. Parental smoking and respiratory tract infections in children. Paediatr Respir Rev. 2001;2:207–13.PubMedGoogle Scholar
  52. 52.
    Searing DA, Rabinovitch N. Environmental pollution and lung effects in children. Curr Opin Pediatr. 2011;23:314–8.CrossRefPubMedGoogle Scholar
  53. 53.
    Sales J, Fivush R, Teague GW. The role of parental coping in children with asthma’s psychological well-being and asthma-related quality of life. J Pediatr Psychol. 2008;33:208–19.CrossRefPubMedGoogle Scholar
  54. 54.
    Barnes PJ. Neuroeffector mechanisms: the interface between inflammation and neuronal responses. J Allergy Clin Immunol. 1996;98:S73–81; discussion S81–3.CrossRefPubMedGoogle Scholar
  55. 55.
    Rosenkranz MA, Busse WW, Sheridan JF, Crisafi GM, Davidson RJ. Are there neurophenotypes for asthma? Functional brain imaging of the interaction between emotion and inflammation in asthma. PLoS One. 2012;7:e40921.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Chen W, Boutaoui N, Brehm JM, et al. ADCYAP1R1 and asthma in Puerto Rican children. Am J Respir Crit Care Med. 2013;187:584–8.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Sandberg S, Paton JY, Ahola S, et al. The role of acute and chronic stress in asthma attacks in children. Lancet. 2000;356:982–7.CrossRefPubMedGoogle Scholar
  58. 58.
    Lietzén R, Virtanen P, Kivimäki M, Sillanmäki L, Vahtera J, Koskenvuo M. Stressful life events and the onset of asthma. Eur Respir J. 2011;37:1360–5.CrossRefPubMedGoogle Scholar
  59. 59.
    Yorke J, Shuldham C. Family therapy for chronic asthma in children. Cochrane Database Syst Rev. 2005;2:CD000089.Google Scholar
  60. 60.
    Fitzpatrick AM, Teague WG, Meyers DA, et al. Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institute of Health/National Heart, Lung and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol. 2011;127:382–9.e1-13.CrossRefPubMedGoogle Scholar
  61. 61.
    Howrylak JA, Fuhlbrigge AL, Strunk RC, Zeiger RS, Weiss ST, Raby BA. Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications. J Allergy Clin Immunol. 2014;133:1289–300, 1300.e1-12.Google Scholar
  62. 62.
    Zoratti EM, Krouse RZ, Babineau DC, et al. Asthma phenotypes in inner-city children. J Allergy Clin Immunol. 2016;138:1016–29.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Liu AH, Babineau DC, Krouse RZ, et al. Pathways through which asthma risk factors contribute to asthma severity in inner-city children. J Allergy Clin Immunol. 2016;138:1042–50.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Bossley CJ, Fleming L, Ullmann N, et al. Assessment of corticosteroid response in pediatric patients with severe asthma by using a multidomain approach. J Allergy Clin Immunol. 2016;138:413–20.e6.CrossRefPubMedGoogle Scholar
  65. 65.
    Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2015;136:556–68.CrossRefPubMedGoogle Scholar
  66. 66.
    Milgrom H, Berger W, Nayak A, et al. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics. 2001;108:E36.CrossRefPubMedGoogle Scholar
  67. 67.
    Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med. 2011;364:1005–15.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Farne HA, Wilson A, Powell C, Bax L, Milan SJ. Anti-IL5 therapies for asthma. Cochrane Database Syst Rev. 2017;9:CD010834.PubMedGoogle Scholar
  69. 69.
    Rodrigo GJ, Castro-Rodríguez JA. Tiotropium for the treatment of adolescents with moderate to severe symptomatic asthma: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2015;115:211–6.CrossRefPubMedGoogle Scholar
  70. 70.
    Hamelmann E, Bateman ED, Vogelberg C, et al. Tiotropium add-on therapy in adolescents with moderate asthma: a 1-year randomized controlled trial. J Allergy Clin Immunol. 2016;138:441–50.e8.CrossRefPubMedGoogle Scholar
  71. 71.
    Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013;368:2455–66.CrossRefPubMedGoogle Scholar
  72. 72.
    Corren J, Parnes JR, Wang L, et al. Tezepelumab in adults with uncontrolled asthma. N Engl J Med. 2017;377:936–46.CrossRefPubMedGoogle Scholar
  73. 73.
    Gauvreau GM, Boulet L-P, Leigh R, et al. A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses. Am J Respir Crit Care Med. 2015;191:161–7.CrossRefPubMedGoogle Scholar
  74. 74.
    Gonem S, Berair R, Singapuri A, et al. Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre,s randomised, double-blind, parallel-group, placebo-controlled trial. Lancet Respir Med. 2016;4:699–707.CrossRefPubMedGoogle Scholar
  75. 75.
    Torrego A, Solà I, Munoz AM, et al. Bronchial thermoplasty for moderate or severe persistent asthma in adults. Cochrane Database Syst Rev. 2014;3:CD009910.Google Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2018

Authors and Affiliations

  1. 1.Pediatric Respiratory Medicine, Royal Manchester Children’s HospitalManchester University HospitalsManchesterUK

Personalised recommendations